New patent expiration for Astrazeneca Pharms drug BRILINTA
Annual Drug Patent Expirations for BRILINTA Brilinta is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from two suppliers. There are six patents…
The post New patent expiration for Astrazeneca Pharms drug BRILINTA appeared first on DrugPatentWatch – Make Better Decisions.
The post New patent expiration for Astrazeneca Pharms drug BRILINTA appeared first on DrugPatentWatch – Make Better Decisions.
The post New patent expiration for Astrazeneca Pharms drug BRILINTA appeared first on Biotechblog.